PARI´s eFlow Partnering, in cooperation with partners from the pharmaceutical industry, develops and markets optimised vibrating membrane nebulisers for the administration of innovative medication.
Reliable, durable and tailored to your needs. Our quality standards are evident in every PARI BOY.
The more medication that reaches the lungs per minute, the more efficient a nebuliser system is. Consider the Respirable Drug Delivery Rate (RDDR).
Find out what leading experts say about nebuliser therapy during the coronavirus pandemic.
PARI Medical Ltd are proud to be working with the Asthma UK & British Lung Foundation Partnership, as a member of the Taskforce for Lung Health’s Industries Forum. The Taskforce’s mission is to prevent more people from developing lung disease, and to transform the care of people living with lung disease.
For further information visit their website
Go to Taskforce for Lung Health
Produced by PhysioAssist in France, Simeox technology offers an innovative solution for efficient clearance of the lungs in patients suffering from chronic respiratory conditions. By changing the physical properties of mucus, Simeox helps mobilize mucus from the furthest areas of the lungs. Adrien Mithalal, founder and CEO of PhysioAssist said “At PhysioAssist, our goal is to set Simeox as a standard of care therapy for patients with obstructive pulmonary diseases such as cystic fibrosis, bronchiectasis, COPD and Primary Ciliary Dyskinesia. We proudly believe Simeox can greatly benefit those patients and are delighted that PARI Medical Ltd is distributing the Simeox device in the UK. PhysioAssist and PARI Medical Ltd share the same vision and mission: improving the lives of those affected by respiratory diseases by offering innovative solutions”.
Any questions? You can reach our service center at this number: